Investigational Site Number 840102

Richmond, Virginia 23230

0 studies enrolling now · 1 studies all time

What they study most

Squamous Cell Lung Cancer

Studies at this site

• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed